|
|
|
|
|
Medical errors kill or injure |
|
Many such errors are medication-related |
|
CPOE can reduce medication errors |
|
Therefore |
|
Install CPOE and save lives |
|
|
|
|
|
|
30% U.S.
Hospitals report some CPOE |
|
(many do not allow use by M.D.) |
|
Only 5% require system be used |
|
Over half report usage under 10% |
|
|
|
|
CEO: We don’t make errors here |
|
M.D.: I tried CPOE; I hated it |
|
CFO: Can’t fit in this year’s budget |
|
CIO: We’ll build one in-house |
|
Pharmacist: I already have a system |
|
Board Chair: Let the Feds pay for it |
|
Lawyer: No way; we’ll be sued |
|
|
|
|
|
Legacy siloes |
|
Lack of standards |
|
Constraints on vendors |
|
CPOE requires EMR infrastructure |
|
Not useful without decision support |
|
and |
|
Decision
support requires integration of systems |
|
|
|
|
Factors affecting clinician acceptance |
|
Measuring value of CPOE for health care |
|
Exploring value of CPOE for HSR |
|
Analyzing medical errors in detail |
|
Measuring safety of computer systems |
|
CPOE as a privacy tool |
|
|
|
|
Data entry |
|
Optimal notification methods |
|
Human-computer interface |
|
Threshold for alerts |
|
Amount of time required to use system |
|
|
|
|
|
|
|
|
|
|
Reduce adverse drug events |
|
Alert clinician to dangerous data |
|
Improve sub-optimal practice |
|
Provide point-of-care education |
|
Decrease malpractice costs |
|
Improve hospital bottom line (ROI) |
|
|
|
|
NLM is major source of federal support |
|
Other Institutes may help for gene expression
work |
|
Some work has been self-supported |
|
Vendors do considerable R & D |
|